Meet The Companying Bridging Synthetic Biology Innovation With The World Of Insurance To Ensure Safe Food Production

Aanika Biosciences CEO and co-founder Vishaal Bhuyan showcases his company’s spore tag product, … [+] about to be applied to a field ready for harvest. Aanika Biosciences Vishaal Bhuyan was part...

For Nvidia Stock, It’s Game On!

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...

Inscripta Is Reimagining What The Synthetic Biology Company Of The Future Will Be

Inscripta’s team in Pleasanton, CA Inscripta Inscripta, a global leader in genome engineering, is reshaping the image of a synthetic biology company. Biomanufacturing is set to transform many industri...

Ginkgo Bioworks Fires Up Its Bio Foundry To Take On The Billion-Dollar Enzyme Market

Ginkgo Bioworks banner on the façade of the New York Stock Exchange building. Ginkgo Bioworks Ginkgo Bioworks is getting ready for another year of disrupting the entire biotech industry model with its...

7 Cheap But Risky Biotech Stocks

Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF drop nearly 50%. The other most-watched exchange-traded fund that tracks the biotech sector, the...

Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.

Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...

It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.

My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...

Berkeley Lights Scoops Up IsoPlexis, Creating A Premier Functional Cell Biology Company

Berkeley Lights Inc (NASDAQ: BLI) has agreed to acquire IsoPlexis Corp (NASDAQ: ISO) in an all-stock transaction valued at $57.8 million. The combined company, which will be named PhenomeX, will be an...

Startup Cradle Lets You Design Custom Proteins By Just Typing In A Prompt

Cradle Team at their site in the Netherlands. Cradle There is a new company on the block whose mission is to make programming biology easy. The European startup called Cradle is emerging from stealth ...

White House Inks Strategy To Grow Trillion Dollar US Bioeconomy

White House Inks Strategy to Grow Trillion Dollar US Bioeconomy Dall-e x John Cumbers The US bioeconomy is booming. Valued at nearly one trillion dollars and predicted to grow globally to over $30 tri...

The Days of Big Pharma Are Over. Big Biotech Is on Its Way.

W hen GlaxoSmithKline spins off its enormous division selling drugstore staples like Advil and Tums next month, it will represent more than just the latest shuffling of assets among corporate giants. ...

Five Beaten-Up Biotech Stocks Saw Big Share Purchases

Text size Biotech stocks Kymera, Cullinan Oncology, Repare, Iovance, and Kodiak Sciences are all in the red so far this year, but they’ve seen large stock buys. Dreamstime Biotech stocks have taken so...

Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.

Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...

‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy

If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have stock-market capitalizations that are smaller th...

Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.

Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...

AbbVie, Gilead and 4 Other Defensive Healthcare Stocks With Big Dividend Yields

Text size An AbbVie bio safety hood Courtesy of AbbVie Deep into the second quarter of the year, stocks have yet to recover, and investors are seeking safety in defensive plays. One sector that’s bene...

Covid will never become an endemic virus, scientist warns

JaruekChairak | iStock | Getty Images Covid-19 will never become an endemic illness and will always behave like an epidemic virus, an expert in biosecurity has warned. Raina MacIntyre, a professor of ...

Las Vegas Sands Stock Could See Better Luck Ahead

Text size These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the vi...